In this part of his Pharmaceutical Executive video interview, Ian Chan, CEO of Abpro talks about...
Author - David Miller
FDA Approves Samsung Bioepis Biosimilars Ospomyv and Xbryk
Ospomyv, a biosimilar to Prolia, is indicated for postmenopausal women and men at high risk of...
Pharma Pulse 2/19/25: The Impact of Telehealth Reimbursement...
The latest news for pharma industry insiders.
Global Launch Strategies in the Current Political Climate
James Foster, CEO and co-founder of Virax Biolabs, discusses how global launches are being impacted...
FDA Approves Evrysdi Tablet from Roche for Spinal Muscular...
The approval makes Evrysdi the first and only tablet for treating spinal muscular atrophy.
Epitopea Strikes Research Collaboration with Merck, Appoints...
Under terms of the deal, Epitopea and Merck will work to identify Cryptigen tumor-specific antigens...
EMA Earns EMAS Certification
The agency has received certification with the Eco-Management and Audit Scheme for its commitment...
Former Health Agency Heads React to Federal Layoffs at NIH, CDC...
Former leaders of the CDC, FDA, and other agencies condemned the layoffs.
FDA Grants Full Approval for Symptomatic Tenosynovial Giant Cell...
Tenosynovial giant cell tumor (TGCT) is rare and non-malignant, forming in or near joints, but...
Applyo Jena Closes Successful Series A Funding Round
Led by Bosch Ventures, Applyo Jena’s Series A funding seeks to accelerate the development and...